Patients' characteristics
| AML patients . | N=156 . |
|---|---|
| Median age, y (range) | (63.3 (20–86) |
| Sex, M/F, n | 98/58 |
| AML M0 | 115 |
| AML M1 | 9 |
| AML M2 | 15 |
| AML M4 | 12 |
| AML M5 | 1 |
| s-AML M2 | 1 |
| AML (not further FAB classified) | 3 |
| Median WBC, /μL (range) | 13 300 (49–330 000) |
| Median platelet count, 109/L (range) | 65 000 (49–330 000) |
| Median hemoglobin level, g/dL (range) | 8.9 (3.0–13.8) |
| Median blast count, % (range) | 82 (21–99) |
| AML patients . | N=156 . |
|---|---|
| Median age, y (range) | (63.3 (20–86) |
| Sex, M/F, n | 98/58 |
| AML M0 | 115 |
| AML M1 | 9 |
| AML M2 | 15 |
| AML M4 | 12 |
| AML M5 | 1 |
| s-AML M2 | 1 |
| AML (not further FAB classified) | 3 |
| Median WBC, /μL (range) | 13 300 (49–330 000) |
| Median platelet count, 109/L (range) | 65 000 (49–330 000) |
| Median hemoglobin level, g/dL (range) | 8.9 (3.0–13.8) |
| Median blast count, % (range) | 82 (21–99) |
WBC indicates white blood cell count.